Cardiovascular risk prediction stands at a crossroads where artificial intelligence may fundamentally reshape how physicians identify patients destined for heart attacks and cardiac death. Current practice relies heavily on radiologists' visual interpretation of coronary CT scans, a subjective approach that may miss subtle but critical plaque characteristics that determine future cardiac events.
The CONFIRM2 registry analysis of symptomatic patients undergoing coronary CT angiography demonstrates that AI-guided quantitative coronary computed tomography analysis (AI-QCT) provides superior prognostic accuracy compared to standard human interpretation methods. The AI system quantifies 24 distinct patient-, vessel-, and plaque-level variables across the entire coronary tree, with noncalcified plaque burden and diameter stenosis emerging as the most powerful predictors when combined. This comprehensive quantitative approach outperformed established clinical scoring systems including CAD-RADS, coronary artery calcium scores, and the modified Duke Index in predicting major adverse cardiac events.
This represents a potential paradigm shift from subjective visual assessment to objective, reproducible quantification of coronary disease. The implications extend beyond diagnostic accuracy to treatment stratification, as AI-detected noncalcified plaque burden may identify high-risk patients who appear relatively benign under current visual assessment protocols. However, the technology requires validation across diverse populations and healthcare settings before widespread implementation. The study's focus on symptomatic patients also limits generalizability to screening asymptomatic individuals, where the risk-benefit calculus differs substantially.